National Human Genome Research Institute; Notice of Closed Meeting, 50486 [2011-20687]
Download as PDF
<![CDATA[
50486
Federal Register / Vol. 76, No. 157 / Monday, August 15, 2011 / Notices
before August 22, 2011. Manufacturers
with common interest are urged to
coordinate their oral presentations.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Center for Scientific Review Notice of
Closed Meetings
Dated: August 9, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Human Genome Research Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Human Genome Research
Institute, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
[FR Doc. 2011–20644 Filed 8–12–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSK4SPTVN1PROD with NOTICES
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: September 9, 2011.
Time: 11:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Camilla E. Day, PhD,
Scientific Review Officer, CIDR, National
Human Genome Research Institute, National
Institutes of Health, 5635 Fishers Lane, Suite
4075, Bethesda, MD 20892, 301–402–8837,
camilla.day@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Name of Committee: Board of Scientific
Counselors, National Human Genome
Research Institute.
Date: September 26–27, 2011.
Time: September 26, 2011, 8 a.m. to 7 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, Fifth Floor Conference Room, 50
Center Drive, Bethesda, MD 20892.
Time: September 27, 2011, 8 a.m. to 4 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, Fifth Floor Conference Room, 50
Center Drive, Bethesda, MD 20892.
Contact Person: Claire Kelso, Intramural
Program Specialist, Division of Intramural
Research, Office of the Scientific Director,
National Human Genome Research Institute,
50 South Drive, Building 50, Room 5222,
Bethesda, MD 20892–8002, 301 435–5802,
claire@nhgri.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: August 9, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Dated: August 9, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–20687 Filed 8–12–11; 8:45 am]
[FR Doc. 2011–20688 Filed 8–12–11; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:05 Aug 12, 2011
Jkt 223001
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Oncology
AREA Review.
Date: September 15–16, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Manzoor Zarger, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroplasticity and
Neurotransmitters Study Section.
Date: September 19–20, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Westin Seattle, 1900 Fifth
Avenue, Seattle, WA 98101.
Contact Person: Suzan Nadi, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, 301–435–
1259, nadis@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Behavioral Medicine, Interventions and
Outcomes Study Section.
Date: September 26–27, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: W Chicago Lakeshore, 644 North
Lakeshore Drive, Chicago, IL 60611.
Contact Person: Lee S. Mann, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3186,
MSC 7848, Bethesda, MD 20892, 301–435–
0677, mannl@csr.nih.gov.
E:\FR\FM\15AUN1.SGM
15AUN1
]]>Agencies
[Federal Register Volume 76, Number 157 (Monday, August 15, 2011)]
[Notices]
[Page 50486]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-20687]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Human Genome Research
Institute.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Human Genome Research Institute, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Human Genome Research Institute.
Date: September 26-27, 2011.
Time: September 26, 2011, 8 a.m. to 7 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, Fifth Floor
Conference Room, 50 Center Drive, Bethesda, MD 20892.
Time: September 27, 2011, 8 a.m. to 4 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, Fifth Floor
Conference Room, 50 Center Drive, Bethesda, MD 20892.
Contact Person: Claire Kelso, Intramural Program Specialist,
Division of Intramural Research, Office of the Scientific Director,
National Human Genome Research Institute, 50 South Drive, Building
50, Room 5222, Bethesda, MD 20892-8002, 301 435-5802,
claire@nhgri.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: August 9, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-20687 Filed 8-12-11; 8:45 am]
BILLING CODE 4140-01-P
